If you are a faculty, staff member or student of TTU, TTUHSC, TTUHSC El Paso or ASU and think you may have COVID-19 or have been exposed to the coronavirus, please notify the COVID-19 Response team
0:40 Transmission of COVID-19 among schoolchildren
1:40 Almost 2,200 contacts
2:37 Infection differences in younger versus older children
3:11 Occupations and COVID-19 mortality risk
4:11 36% increase in Latinos
5:12 Treat their lives as essential
6:00 Mental health issues in the pandemic
7:01 Disorders highly prevalent in 18-24-year-olds
8:01 Need to be creative in providing services
9:01 First time with a disruption like the pandemic
10:00 Update on the AstraZeneca vaccine and interval
11:00 Initially was supposed to be a single dose
12:02 Antibodies against more of the spike protein
12:58 End
0:41 Tocilizumab and Covid
1:46 All needed oxygen
2:48 How expensive?
3:18 Exercise and knee osteoarthritis
4:18 High or low intensity strength training
5:18 Very comprehensive study
6:18 Keeping people in the study for 18 months
6:38 Heparin for reducing blood clots in COVID-19
7:40 Subcutaneous injection
8:41 Study coming shortly
9:10 Human gut microbiome and health
10:10 Driven by healthy and plant based foods
11:10 Less of one bug in the gut may be associated with CVD
12:10 Is it a cause or an effect?
13:15 End
0:40 Benefits of masking in reducing hospitalizations
1:40 99 counties in 14 states
2:40 Most older individuals wear masks already
3:30 Transmission of Sars-CoV2 in daycare centers
4:35 Overall seroprevalence examined
5:35 Kids transmission would be rampant
6:30 Most kids got it from home
6:40 Misinformation and vaccine hesitancy
7:40 54% in U.K. said they would take it before
8:40 What is a free press?
9:41 Prediabetes in older folks
10:41 HbA1c and progression examined
11:41 Didn't impact overall mortality
13:04 End
0:58 Russian vaccine
1:58 Robust T cell response
2:58 Prominent in mRNA also
3:13 AstraZeneca vaccine
4:13 Report efficacy of 66.7% overall
5:13 Natural experiment data
6:10 Do get additional antibody after second dose
6:50 Maternal fetal transmission of COVID-19 antibodies
7:50 More antibodies than the mother
8:50 Benefits outweigh risk
9:10 Long term sequelae of COVID-19
10:10 Diabetes at 4% in this study
11:12 Symptoms after acute phase
12:07 End
0:40 Potential for allergic reactions after Moderna vaccine
1:39 Previous history of allergic reaction
2:41 Resuscitation with epinephrine
3:40 Over 23 million doses so far
4:01 Two IUDs for emergency contraception
5:01 Non-inferiority trial
6:01 As effective as copper IUD
6:30 COVID-19 transmission in schools
7:31 Compared with community transmission
8:28 Could kids be safer in school?
9:16 Resumption of cardiac activity after life-support withdrawal
10:17 Incidence and timing of resumption
11:15 Some cardiac activity in 14%
12:15 All electrical activity ceases
13:15 Neurological definition of death
14:04 End
0:41 The impact of masks
1:42 Usage varied across the U.S.
2:41 Targeted control measures
3:05 Oxygen targets in people with acute respiratory failure
4:05 Should we target lower or higher oxygen?
5:05 In COVID-19 does it inform?
5:45 Blood pressure medicines and COVID-19
6:45 Discontinuing did not improve outcome
7:31 Smoking cessation and USPSTF update
8:31 Need to use medicines
9:31 National survey shows only 1/3 used aids to quit
11:00 End
0:48 Persistent symptoms following hospitalization for COVID-19
1:48 Lung problems seen
2:48 Give us opportunity to continue follow up
3:11 Saliva versus nasopharyngeal swab for COVID-19
4:15 Almost eight percentage points lower with saliva
5:15 Could be a false negative
6:18 Bring up secretions from respiratory tract
7:15 Antibodies to variant of SARS-CoV2 from vaccination
8:17 Laboratory generated variant
9:15 mRNA technology can be rapidly adjusted
9:36 Methamphetamine use disorder
10:36 First stage half treated
11:36 Stimulant-like medicine
12:27 It's a 12-week study
13:08 End
0:45 Dietary guidelines
1:45 A lifespan approach
2:45 Make every bite count
3:44 Make easily remembered recommendations
4:00 Using convalescent plasma in early COVID-19
5:00 What are the barriers to using this?
6:01 This study sheds light
7:00 Avoiding graft versus host disease
8:01 Gave sitagliptin
9:01 An example of a beneficial side effect
9:16 Can we modify the COVID-19 vaccine dosing?
10:15 Still end up with better pandemic control
11:15 Getting more vaccine isn't the problem now
12:15 Protecting more people
13:14 End
0:48 Do antibodies protect against COVID-19?
1:50 Reduction of about 90%
2:53 Second variant
3:22 Health outcomes of privileged U.S. citizens
4:24 Compared with 12 other developed countries
5:24 Can't buy our way out of subpar outcomes
6:26 Outcomes may not always be better
7:26 Patient characteristics associated with telemedicine access
8:28 Only half of scheduled visits completed
9:29 Historically for movement disorders
10:22 Beverage tax imposed and repealed
11:22 Public education needed
12:28 Tied to health consequences
13:50 End
Take a moment to enjoy this week’s Tech Talk: HSC El Paso video! Tech Talk: HSC El
Paso provides you with a roundup of information and events happening on campus!
